Advancements that could lead to earlier diagnosis and treatment for diabetic retinopathy, a common complication that affects the eyes, have been identified by a multi-department research team from Michigan State and other universities.
Curaleaf Q2 Revenue Lifts 1% Sequentially
Curaleaf Reports Second Quarter 2023 Results Second quarter 2023 revenue of $339 million, representing an increase of 4% year-over-year, and adjusted EBITDA¹ of $70 million
August 10, 2023